The drug eBAT is a bispecific angiotoxin targeted to both tumor and tumor neovasculature for sarcomas. It has been shown effectively kills canine hemangiosarcoma and human sarcoma cells in vitro. The
IDH1 mutations are closely related to the development and progression of various human cancers, such as glioblastoma, sarcoma, and acute myeloid leukemia. By screening dozens of reported natural compo
EORTC-SPECTA RP1759 study focuses on cancers in adolescent and young adult (AYA), age 12 to 29 years. This study explicitly recruited AYA patients and therefore collected empirical data to bridge the